VVP
PFE icon

Venture Visionary Partners’s Pfizer PFE Stock Holding History

Venture Visionary Partners’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.89M Buy
161,492
+2,096
+1% +$54.8K 0.11% 174
2026
Q1 		$4.48M Buy
159,396
+506
+0.3% +$13.5K 0.15% 147
2025
Q4 		$4.03M Sell
158,890
-24,774
-13% -$625K 0.13% 147
2025
Q3 		$4.68M Sell
183,664
-9,107
-5% -$225K 0.16% 134
2025
Q2 		$4.67M Sell
192,771
-204,375
-51% -$4.77M 0.18% 127
2025
Q1 		$10.1M Buy
397,146
+19,737
+5% +$516K 0.42% 60
2024
Q4 		$10M Sell
377,409
-53,843
-12% -$1.46M 0.42% 62
2024
Q3 		$12.5M Buy
431,252
+8,385
+2% +$245K 0.54% 44
2024
Q2 		$11.8M Buy
422,867
+117,925
+39% +$3.25M 0.54% 42
2024
Q1 		$8.46M Buy
304,942
+20,967
+7% +$582K 0.4% 66
2023
Q4 		$8.18M Sell
283,975
-2,337
-0.8% -$70.6K 0.43% 60
2023
Q3 		$9.5M Sell
286,312
-255
-0.1% -$9.02K 0.57% 40
2023
Q2 		$10.5M Buy
286,567
+1,941
+0.7% +$75.5K 0.62% 34
2023
Q1 		$11.6M Buy
284,626
+10,674
+4% +$461K 0.74% 30
2022
Q4 		$14M Buy
273,952
+13,297
+5% +$638K 1.02% 19
2022
Q3 		$11.4M Buy
260,655
+6,838
+3% +$332K 0.93% 25
2022
Q2 		$13.3M Buy
253,817
+11,330
+5% +$577K 1.01% 22
2022
Q1 		$12.6M Buy
242,487
+18,527
+8% +$961K 0.84% 30
2021
Q4 		$13.3M Buy
223,960
+9,053
+4% +$449K 0.86% 27
2021
Q3 		$9.26M Buy
214,907
+31,628
+17% +$1.4M 0.66% 37
2021
Q2 		$7.19M Buy
183,279
+24,521
+15% +$954K 0.58% 37
2021
Q1 		$5.75M Buy
158,758
+35,541
+29% +$1.26M 0.48% 47
2020
Q4 		$4.54M Buy
123,217
+74,002
+150% +$2.71M 0.5% 44
2020
Q3 		$1.71M Buy
49,215
+19,770
+67% +$693K 0.42% 44
2020
Q2 		$913K Buy
29,445
+4
+0% +$136 0.27% 55
2020
Q1 		$911K Buy
29,441
+6,237
+27% +$213K 0.34% 46
2019
Q4 		$862K Buy
+23,204
New +$827K 0.26% 59

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Venture Visionary Partners's PFE Position: Q2 2026 in Review

Venture Visionary Partners increased its Pfizer (PFE) stake by 1.3% in Q2 2026, buying an estimated $54.8K and bringing the position to 161,492 shares worth $3.89M. The position accounts for 0.11% of the portfolio, ranked #174.

Venture Visionary Partners first reported a position in PFE in Q4 2019 and has held it in 27 quarters since. The position peaked at $14M in Q4 2022. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Venture Visionary Partners held 161,492 shares of Pfizer worth $3.89M as of Q2 2026.
  • Venture Visionary Partners bought 2,096 Pfizer shares in Q2 2026, an estimated $54.8K.
  • Pfizer made up 0.11% of Venture Visionary Partners's portfolio in Q2 2026, its #174 holding.
  • Venture Visionary Partners first reported a position in Pfizer in Q4 2019 and has held it in 27 quarters since.
  • Venture Visionary Partners's Pfizer position peaked at $14M in Q4 2022.
  • 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Venture Visionary Partners's 13F filing for Q2 2026, filed 27 Jul 2026.